ArticleNational journal of maxillofacial surgery
Cancer stem cell marker ALDH1 and CD44 expression: Independent predictors of survival outcome in oral cancer patients.
Article in National journal of maxillofacial surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oral squamous cell carcinoma (OSCC) significantly impacts global cancer incidence, with cancer stem cells (CSCs) such as ALDH1 and CD44 promoting tumor growth and self-renewal. This study examines the correlation between these CSC markers ALDH1 and CD44 with clinicopathological factors and survival outcomes in OSCC patients. Materials and Methods: The expression of cancer markers in 161 tumor tissue blocks was assessed through Immunohistochemistry (IHC). Fluorescence-activated cell sorting (FACS) was used to identify the immunoexpression of CD44 and ALDH1 in primary oral cancer cell lines derived from patients. The five-year survival outcome was calculated by Kaplan Meier (KM). Results: Our five-year study found significant associations between CSC markers and clinicopathological factors in OSCC patients. ALDH1 was linked to lymph node metastasis ( Conclusion: This study aimed to identify ALDH1 and CD44 expressions as cancer stem cell markers and independent predictors of lower five-year disease-free survival (DFS) and overall survival (OS), respectively. These markers effectively predict oral cancer prognosis and treatment response, enabling clinicians to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.